{
  "docId": "019dd923-622c-750b-8b9a-4b91788fc785",
  "docSlug": "5fadb686cc03",
  "documentTitle": "Twist Bioscience (TWST)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2022-11-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 177,
  "pageCount": 236,
  "prevPage": 176,
  "nextPage": 178,
  "slideType": "quote_slide",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses Q&A transcripts to undermine the competitive moat of the subject company (Twist).",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-4b91788fc785/177",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785#slide-177",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Commodity market without any major player that is “really sticking out”",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0932-77cf-bff3-881ad5a569cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Commodity market without any major player that is “really sticking out”\nQ: “Are regular single-gene synthesis, oligo pools, NGS’s, basically a commodity product you can go to 10 different players for?”\nA: “Yeah, you can go to a lot of places for that.”\nQ: “Is it basically identical?”\nA: “Your turnaround time might be different by a little bit. Your quality might be a little bit different. I don’t know that there’s any one place really sticking out. IDT has a great reputation for quality and being reliable, and a lot of people stick with them because of that. Some big companies just already have GenScript in their ordering system, and it’s hard to get people to make changes.” -Executive recently at IDT, a key Twist competitor; currently employed at another synthetic biology player",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5483bfc-331f-4cfb-b246-8cec313ec3c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Key Twist competitor: “crowded market” with “lots of people making double-stranded DNA”\n“I was listing off examples of what I would include in the synthetic biology applications arena. The products that usually go into that space are double-stranded DNA constructs. These would be the IDT G-blocks. It’s a crowded market. There are lots of people making double-stranded DNA constructs in a variety of sizes, from half a kilobase to 10 kilobases at the very largest end..” – IDT ex-regional sales manager, left recently",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee9af6ee-2275-4a6d-876b-c573e865a3d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I don’t know that there’s any one place really sticking out. IDT has a great reputation for quality and being reliable, and a lot of people stick with them because of that. Some big companies just already have GenScript in their ordering system, and it’s hard to get people to make changes.” — Executive recently at IDT, a key Twist competitor; currently employed at another synthetic biology player",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0932-77cf-bff3-8e8dca2696d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "270d69f5-ae2a-45f4-8bda-952612aabd2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Danaher’s IDT division, Twist’s other key competitor, similarly called it a commodity market where “you can go to a lot of places for” gene synthesis, NGS, and oligo pools – “I don’t know that there’s any one place really sticking out...it’s hard to get people to make changes.” He continued that it’s a “crowded market” with “lots of people making double-stranded DNA.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "893a8539-1e26-463c-801a-d36de63e96e4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "e1f1d206-f01a-4399-bed0-96c14b397047",
      "evidence": "Uses expert testimony to validate market claims",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}